DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.74

EPS Forecast

$11.95

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncTECHBio-techne CorpNVAXNovavax IncCRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncRGENRepligen CorpMRNAModerna Inc